FFCP PHASE2:Hg19::chr17:38020392..38020477,-: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=entrezgene:22806 |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding |HGNC=HGNC:13178 |TSScla...") |
No edit summary |
||
| Line 2: | Line 2: | ||
|DHSsupport=supported | |DHSsupport=supported | ||
|DPIdataset=robust | |DPIdataset=robust | ||
|EntrezGene= | |EntrezGene=22806 | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | ||
|HGNC= | |HGNC=13178 | ||
|TSSclassifier=strong | |TSSclassifier=strong | ||
|UniProt= | |UniProt=Q9UKT9 | ||
|association_with_transcript=0bp_to_ENST00000293068,ENST00000346872,ENST00000348427,ENST00000377944,ENST00000377945,ENST00000377952,ENST00000377958,ENST00000394189,ENST00000488188,ENST00000535189,NM_012481,NM_183228,NM_183229,NM_183230,NM_183231,NM_183232,uc002hsu.2,uc002hsv.2,uc002hsw.2,uc002hsx.2,uc002hsy.2,uc002hsz.2,uc002hta.2,uc002htb.2,uc002htc.2,uc002htd.2,uc010cwd.2,uc010cwe.2,uc010cwf.2,uc010cwg.2,uc010cwh.2_5end | |association_with_transcript=0bp_to_ENST00000293068,ENST00000346872,ENST00000348427,ENST00000377944,ENST00000377945,ENST00000377952,ENST00000377958,ENST00000394189,ENST00000488188,ENST00000535189,NM_012481,NM_183228,NM_183229,NM_183230,NM_183231,NM_183232,uc002hsu.2,uc002hsv.2,uc002hsw.2,uc002hsx.2,uc002hsy.2,uc002hsz.2,uc002hta.2,uc002htb.2,uc002htc.2,uc002htd.2,uc010cwd.2,uc010cwe.2,uc010cwf.2,uc010cwg.2,uc010cwh.2_5end | ||
|cluster_id=chr17:38020392..38020477,- | |cluster_id=chr17:38020392..38020477,- | ||
Latest revision as of 23:06, 19 September 2015
| Short description: | p1@IKZF3 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_IKZF3_5end |
| Coexpression cluster: | C1325_CD19_cord_Eosinophils_b_B_Neutrophils_acute |
| Association with transcript: | 0bp_to_ENST00000293068, ENST00000346872, ENST00000348427, ENST00000377944, ENST00000377945, ENST00000377952, ENST00000377958, ENST00000394189, ENST00000488188, ENST00000535189, NM_012481, NM_183228, NM_183229, NM_183230, NM_183231, NM_183232, uc002hsu.2, uc002hsv.2, uc002hsw.2, uc002hsx.2, uc002hsy.2, uc002hsz.2, uc002hta.2, uc002htb.2, uc002htc.2, uc002htd.2, uc010cwd.2, uc010cwe.2, uc010cwf.2, uc010cwg.2, uc010cwh.2_5end |
| EntrezGene: | IKZF3 |
| HGNC: | 13178 |
| UniProt: | Q9UKT9 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| lymphocyte | 3.15e-56 | 53 |
| common lymphoid progenitor | 3.15e-56 | 53 |
| lymphoid lineage restricted progenitor cell | 6.30e-55 | 52 |
| leukocyte | 2.92e-48 | 136 |
| hematopoietic cell | 5.65e-41 | 177 |
| hematopoietic stem cell | 2.11e-40 | 168 |
| hematopoietic lineage restricted progenitor cell | 5.39e-39 | 120 |
| nongranular leukocyte | 6.49e-39 | 115 |
| hematopoietic oligopotent progenitor cell | 3.21e-36 | 161 |
| hematopoietic multipotent progenitor cell | 3.21e-36 | 161 |
| lymphocyte of B lineage | 3.48e-31 | 24 |
| pro-B cell | 3.48e-31 | 24 |
| T cell | 3.79e-21 | 25 |
| pro-T cell | 3.79e-21 | 25 |
| mature alpha-beta T cell | 1.03e-19 | 18 |
| alpha-beta T cell | 1.03e-19 | 18 |
| immature T cell | 1.03e-19 | 18 |
| mature T cell | 1.03e-19 | 18 |
| immature alpha-beta T cell | 1.03e-19 | 18 |
| B cell | 6.09e-19 | 14 |
| CD8-positive, alpha-beta T cell | 2.50e-13 | 11 |
| CD4-positive, alpha-beta T cell | 2.57e-07 | 6 |
| mesenchymal cell | 5.69e-07 | 354 |
| Ontology term | p-value | n |
|---|---|---|
| blood | 4.91e-17 | 15 |
| haemolymphatic fluid | 4.91e-17 | 15 |
| organism substance | 4.91e-17 | 15 |
| hematopoietic system | 7.24e-14 | 98 |
| blood island | 7.24e-14 | 98 |
| hemolymphoid system | 5.24e-13 | 108 |
| hemopoietic organ | 1.58e-08 | 7 |
| immune organ | 1.58e-08 | 7 |
| Ontology term | p-value | n |
|---|---|---|
| lymphoma | 4.23e-08 | 10 |
